oa Cardiac amyloidosis and hypertrophic cardiomyopathy: A dangerous liaison

References

1. Dubrey SW, Hawkins PN, Falk RH. Amyloid diseases of the heart: assessment, diagnosis, and referral. Heart. 2011; 97::75–84.
   [Google Scholar]
2. Dubrey SW, Cha K, Anderson J, Chamarthi B, Reisinger J, Skinner M, Falk RH. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM. 1998; 9::141–157.
   [Google Scholar]
3. Dubrey SW, Comenzo RL. Amyloid diseases of the heart: current and future therapies. QJM. 2012; 105::617–631.
   [Google Scholar]
4. Falk RH. Diagnosis and management of the cardiac amyloidosis. Circulation. 2005; 112::2047–2060.
   [Google Scholar]
5. Kapoor P, Thenappan T, Singh E, Kumar S, Greipp PR. Cardiac amyloidosis: a practical approach to diagnosis and management. Am J Med. 2011; 124::1006–1015.
   [Google Scholar]
6. Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, Cecchi F, Maron BJ. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med. 2003; 348::295–303.
   [Google Scholar]
7. Philippakis AA, Falk RH. Cardiac amyloidosis mimicking hypertrophic cardiomyopathy with obstruction: treatment with disopyramide. Circulation. 2012; 125::1821–1824.
   [Google Scholar]
8. Mörner S, Hellman U, Suhr OB, Kazzam E, Waldenström A. Amyloid heart disease mimicking hypertrophic cardiomyopathy. J Intern Med. 2005; 258::225–230.
   [Google Scholar]
9. Dinwoodey DL, Skinner M, Maron MS, Davidoff R, Ruberg FL. Light-chain amyloidosis with echocardiographic features of hypertrophic cardiomyopathy. Am J Cardiol. 2008; 101::674–676.
   [Google Scholar]
10. Oh JK, Tajik AJ, Edwards WD, Bresnahan JF, Kyle RA. Dynamic left ventricular outflow tract obstruction in cardiac amyloidosis detected by continuous-wave Doppler echocardiography. Am J Cardiol. 1987; 59::1008–1010.
    [Google Scholar]
11. Presti CF, Waller BF, Armstrong WF. Cardiac amyloidosis mimicking the echocardiographic appearance of obstructive hypertrophic myopathy. Chest. 1988; 93::881–883.
    [Google Scholar]
12. Liu D, Niemann M, Hu K, Herrmann S, Störk S, Knop S, Ertl G, Weidemann F. Echocardiographic evaluation of systolic and diastolic function in patients with cardiac amyloidosis. Am J Cardiol. 2011; 108::591–598.
    [Google Scholar]
13. Maceira AM, Joshi J, Prasad SK, Moon JC, Perugini E, Harding I, Sheppard MN, Poole-Wilson PA, Hawkins PN, Pennell DJ. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2005; 111::186–193.
    [Google Scholar]